 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | ALLOCSC-01 / Takeda
Clinical, Journal: Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients with ST-segment Elevation Myocardial Infarction and Left Ventricular Dysfunction: A Multicenter Randomized, Double-Blind and Placebo-Controlled Clinical Trial. (Pubmed Central) - Oct 2, 2019
P1/2
Allogeneic cardiac stem cells (AlloCSC-01) have shown protective, immunoregulatory, and regenerative properties with a robust safety profile in large animal models of heart disease...Allogeneic cardiac stem cells can be safely administered in STEMI patients with LV dysfunction early after revascularization. Low immunogenicity and absence of immune-mediated events will facilitate adequately powered studies to demonstrate their clinical efficacy in this setting.Clinical Trial Registration: NCT 02439398.
- || ALLOCSC-01 / Takeda
Mar 2018 (CTX101) vs Mar 2019 (CTX110) $CRSP (Twitter) - Jul 29, 2019
- | ALLOCSC-01 / Takeda
Anyone know the difference between CTX101 and CTX110? $CRSP (Twitter) - Jul 29, 2019
- |||| ALLOCSC-01 / Takeda
Trial completion: CAREMI: Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI (clinicaltrials.gov) - Nov 14, 2017
P1/2, N=55, Completed, Sponsor: Coretherapix
Low immunogenicity and absence of immune-mediated events will facilitate adequately powered studies to demonstrate their clinical efficacy in this setting.Clinical Trial Registration: NCT 02439398. Active, not recruiting --> Completed
- ||| ALLOCSC-01 / Takeda
Enrollment closed: CAREMI: Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI (clinicaltrials.gov) - Nov 19, 2015
P1/2, N=55, Active, not recruiting, Sponsor: Coretherapix
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| ALLOCSC-01 / Takeda
New P1/2 trial: CAREMI: Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI (clinicaltrials.gov) - May 8, 2015
P1/2, N=55, Recruiting, Sponsor: Coretherapix